| Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024 | 09/15 08:45 | globenewswire.com |
| Lantheus Appoints Julie Eastland as New Board Member | 09/05 08:30 | globenewswire.com |
| Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference | 08/28 08:30 | globenewswire.com |
| Lantheus: A Radiopharmaceutical Powerhouse In The Making (Q2 2024 Update) | 08/12 15:32 | seekingalpha.com |
| 13 stocks to consider if you're able to brave recession fears | 08/12 07:15 | marketwatch.com |
| Lantheus Reports Second Quarter 2024 Financial Results | 07/31 07:00 | globenewswire.com |
| Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time | 07/17 08:30 | globenewswire.com |
| Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer's Disease | 07/15 08:30 | globenewswire.com |
| Lantheus Welcomes CMS' Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access | 07/10 12:32 | globenewswire.com |
| Why Lantheus Holdings Stock Is Skyrocketing Today | 07/10 11:57 | fool.com |